Abstract
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the striatum. Loss-of-function mutations in the DJ-1 gene cause early-onset familial parkinsonism. To investigate a possible role for DJ-1 in the dopaminergic system, we generated a mouse model bearing a germline disruption of DJ-1. Although DJ-1(-/-) mice had normal numbers of dopaminergic neurons in the substantia nigra, evoked dopamine overflow in the striatum was markedly reduced, primarily as a result of increased reuptake. Nigral neurons lacking DJ-1 were less sensitive to the inhibitory effects of D2 autoreceptor stimulation. Corticostriatal long-term potentiation was normal in medium spiny neurons of DJ-1(-/-) mice, but long-term depression (LTD) was absent. The LTD deficit was reversed by treatment with D2 but not D1 receptor agonists. Furthermore, DJ-1(-/-) mice displayed hypoactivity in the open field. Collectively, our findings suggest an essential role for DJ-1 in dopaminergic physiology and D2 receptor-mediated functions.
MeSH Terms
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology
Age Factors
Animals
Behavior, Animal
Blotting, Southern/methods
Blotting, Western/methods
Cell Count
Cerebral Cortex/cytology,physiology
Disease Models, Animal
Dopamine/deficiency
Dopamine Agonists/pharmacology
Dopamine Plasma Membrane Transport Proteins
Electric Stimulation/methods
Electrochemistry/methods
Excitatory Postsynaptic Potentials/drug effects,physiology
Germ-Line Mutation
Humans
Hypokinesia/physiopathology
Immunohistochemistry/methods
In Vitro Techniques
Intracellular Signaling Peptides and Proteins
Membrane Glycoproteins/metabolism
Membrane Transport Proteins/metabolism
Mice
Mice, Inbred C57BL
Mice, Transgenic
Nerve Tissue Proteins/metabolism
Neurons/physiology
Oncogene Proteins/physiology
Parkinsonian Disorders/genetics,metabolism
Protein Deglycase DJ-1
Quinpirole/pharmacology
RNA, Messenger/biosynthesis
Radioligand Assay/methods
Receptors, Dopamine D2/metabolism
Reverse Transcriptase Polymerase Chain Reaction/methods
Substantia Nigra/cytology,drug effects,metabolism
Tyrosine 3-Monooxygenase/metabolism
Chemicals
Dopamine Agonists
Dopamine Plasma Membrane Transport Proteins
Intracellular Signaling Peptides and Proteins
Membrane Glycoproteins
Membrane Transport Proteins
Nerve Tissue Proteins
Oncogene Proteins
RNA, Messenger
Receptors, Dopamine D2
Quinpirole
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
Tyrosine 3-Monooxygenase
PARK7 protein, human
Protein Deglycase DJ-1
Dopamine
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Goldberg Matthew S
Center for Neurologic Diseases, Brigham & Women's Hospital, Program in Neuroscience, Harvard Medical School, Boston, Massachusetts 02115, USA.
Pisani Antonio
Haburcak Marian
Vortherms Timothy A
Kitada Tohru
Costa Cinzia
Tong Youren
Martella Giuseppina
Tscherter Anne
Martins Andrea
Bernardi Giorgio
Roth Bryan L
Pothos Emmanuel N
Calabresi Paolo
Shen Jie